Trial Profile
Phase I study of ORY-2001 in patiemts with multiple-sclerosis
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Vafidemstat (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 26 Dec 2016 New trial record
- 21 Dec 2016 According to an Oryzon media release, this study is expected to finish in the next months.